Wells Fargo
BNTX icon

Wells Fargo’s BioNTech BNTX Stock Holding History

Wells Fargo’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
17,973
+2,160
+14% +$203K ﹤0.01% 3743
2026
Q1 		$1.41M Buy
15,813
+10,111
+177% +$1.04M ﹤0.01% 3530
2025
Q4 		$543K Sell
5,702
-610
-10% -$61.5K ﹤0.01% 4429
2025
Q3 		$622K Sell
6,312
-1,872
-23% -$200K ﹤0.01% 4137
2025
Q2 		$871K Sell
8,184
-11,133
-58% -$1.12M ﹤0.01% 3779
2025
Q1 		$1.76M Sell
19,317
-4,523
-19% -$506K ﹤0.01% 3264
2024
Q4 		$2.72M Sell
23,840
-5,880
-20% -$671K ﹤0.01% 2954
2024
Q3 		$3.53M Sell
29,720
-50,362
-63% -$4.63M ﹤0.01% 2634
2024
Q2 		$6.44M Sell
80,082
-5,098
-6% -$466K ﹤0.01% 2074
2024
Q1 		$7.86M Buy
85,180
+3,009
+4% +$289K ﹤0.01% 1936
2023
Q4 		$8.67M Buy
82,171
+5,227
+7% +$527K ﹤0.01% 1811
2023
Q3 		$8.36M Buy
76,944
+6,638
+9% +$734K ﹤0.01% 1698
2023
Q2 		$7.59M Buy
70,306
+12,839
+22% +$1.44M ﹤0.01% 1810
2023
Q1 		$7.16M Buy
57,467
+6,284
+12% +$863K ﹤0.01% 1838
2022
Q4 		$7.69M Sell
51,183
-9,179
-15% -$1.41M ﹤0.01% 1734
2022
Q3 		$8.14M Buy
60,362
+6,984
+13% +$1.07M ﹤0.01% 1672
2022
Q2 		$7.96M Sell
53,378
-13,064
-20% -$2M ﹤0.01% 1738
2022
Q1 		$11.3M Sell
66,442
-18,487
-22% -$3.11M ﹤0.01% 1727
2021
Q4 		$21.9M Buy
84,929
+5,555
+7% +$1.52M 0.01% 1272
2021
Q3 		$21.7M Buy
79,374
+5,658
+8% +$1.8M ﹤0.01% 1597
2021
Q2 		$16.5M Buy
73,716
+10,134
+16% +$1.91M ﹤0.01% 1825
2021
Q1 		$6.94M Sell
63,582
-12,395
-16% -$1.32M ﹤0.01% 2523
2020
Q4 		$6.19M Buy
75,977
+64,594
+567% +$6.34M ﹤0.01% 2533
2020
Q3 		$788K Buy
11,383
+1,928
+20% +$138K ﹤0.01% 4034
2020
Q2 		$631K Buy
9,455
+9,124
+2,756% +$456K ﹤0.01% 4158
2020
Q1 		$20K Buy
+331
New +$12.9K ﹤0.01% 5599

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Wells Fargo's BNTX Position: Q2 2026 in Review

Wells Fargo increased its BioNTech (BNTX) stake by 14% in Q2 2026, buying an estimated $203K and bringing the position to 17,973 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

Wells Fargo first reported a position in BNTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $21.9M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Wells Fargo held 17,973 shares of BioNTech worth $1.67M as of Q2 2026.
  • Wells Fargo bought 2,160 BioNTech shares in Q2 2026, an estimated $203K.
  • BioNTech made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3743 holding.
  • Wells Fargo first reported a position in BioNTech in Q1 2020 and has held it in 26 quarters since.
  • Wells Fargo's BioNTech position peaked at $21.9M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.